A silver-alginate-coated dressing to reduce peripherally inserted central catheter (PICC) infections in NICU patients: A pilot randomized controlled trial

Journal of Perinatology

Volumn 30, Issue 7, 2010, Pages 469-473

  Hill, M L ^a   Baldwin, L ^a   Slaughter, J C ^b   Walsh, W F ^a   Weitkamp, J H ^a  

^a MONROE CARELL JR CHILDREN S HOSPITAL AT VANDERBILT   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

catheter related infections; health care associated infections; infants; premature; sepsis; silver compounds

Indexed keywords

ALGINIC ACID; MALTODEXTRIN; SILVER;

ARTICLE; BIRTH WEIGHT; CATHETER INFECTION; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; GESTATIONAL AGE; HUMAN; INFANT; INFECTION PREVENTION; MAJOR CLINICAL STUDY; MALE; NEWBORN; NEWBORN INTENSIVE CARE; PATIENT ASSESSMENT; PATIENT SAFETY; PERIPHERALLY INSERTED CENTRAL VENOUS CATHETER; PILOT STUDY; RANDOMIZED CONTROLLED TRIAL; TRANSPARENT DRESSING; TREATMENT DURATION;

ADMINISTRATION, CUTANEOUS; ALGINATES; ANTI-BACTERIAL AGENTS; BANDAGES; CATHETERIZATION, CENTRAL VENOUS; CATHETERS, INDWELLING; FEMALE; GLUCURONIC ACID; HEXURONIC ACIDS; HUMANS; INFANT, NEWBORN; MALE; PILOT PROJECTS; POLYSACCHARIDES; SEPSIS; SILVER; TREATMENT OUTCOME;

EID: 77954242491     PISSN: 07438346     EISSN: 14765543     Source Type: Journal    
DOI: 10.1038/jp.2009.190     Document Type: Article

References (19)

1. Stoll BJ, Hansen N, Fanaroff AA, Wright LL, Carlo WA, Ehrenkranz RA et al. Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics 2002; 110: 285-291.
2. Stoll BJ, Hansen NI, Adams-Chapman I, Fanaroff AA, Hintz SR, Vohr B et al. National Institute of Child Health and Human Development Neonatal Research Network. Neurodevelopmental and growth impairment among extremely low-birth-weight infants with neonatal infection. JAMA 2004; 292: 2357-2365.
3. Timsit JF, Schwebel C, Bouadma L, Geffroy A, Garrouste-Orgeas M, Pease S et al. Chlorhexidine-impregnated sponges and less frequent dressing changes for prevention of catheter-related infections in critically ill adults: a randomized controlled trial. JAMA 2009; 301: 1231-1241.
4. Costello JM, Morrow DF, Graham DA, Potter-Bynoe G, Sandora TJ, Laussen PC. Systematic intervention to reduce central line-associated bloodstream infection rates in a pediatric cardiac intensive care unit. Pediatrics 2008; 121: 915-923.
5. Ho KM, Litton E. Use of chlorhexidine-impregnated dressing to prevent vascular and epidural catheter colonization and infection: a meta-analysis. J Antimicrob Chemother 2006; 58: 281-287.
6. Garland JS, Alex CP, Mueller CD, Otten D, Shivpuri C, Harris MC et al. A randomized trial comparing povidone-iodine to a chlorhexidine gluconate-impregnated dressing for prevention of central venous catheter infections in neonates. Pediatrics 2001; 107: 1431-1436.
7. Cartwright DW. Central venous lines in neonates: a study of 2186 catheters. Arch Dis Child Fetal Neonatal Ed 2004; 89: F504-F508.
8. Khattak AZ, Ross RE, Arnold C, Tiffany N, Shoemaker CT. A randomized controlled trial of the safety of silver alginate (Algidex) patches in very low birth weight (VLBW) infants with central lines. Annual Meeting of the American Pediatric Society and Society for Pediatric Research, Hawaii, May 2008: 284. (abstract 665).
9. Agency for Toxic Substances and Disease Registry (ATSDR). Toxicological Profile for Silver. www.atsdr.cdc.gov/toxprofiles/phs146.html.
10. Eypasch E, Lefering R, Kum CK, Troidl H. Probability of adverse events that have not yet occurred: a statistical reminder. BMJ 1995; 311: 619-620.
11. Garland JS, Alex CP, Sevallius JM, Murphy DM, Good MJ, Volberding AM et al. Cohort study of the pathogenesis and molecular epidemiology of catheter-related bloodstream infection in neonates with peripherally inserted central venous catheters. Infect Control Hosp Epidemiol 2008; 29: 243-249.
12. Costa SF, Miceli MH, Anaissie EJ. Mucosa or skin as source of coagulase-negative staphylococcal bacteraemia? Lancet Infect Dis 2004; 4: 278-286.
13. Wildhaber BE, Yang H, Spencer AU, Drongowski RA, Teitelbaum DH. Lack of enteral nutritionFeffects on the intestinal immune system. J Surg Res 2005; 123: 8-16.
14. Barreau F, Ferrier L, Fioramonti J, Bueno L. Neonatal maternal deprivation triggers long term alterations in colonic epithelial barrier and mucosal immunity in rats. Gut 2004; 53: 501-506.
15. Lachman P, Yuen S. Using care bundles to prevent infection in neonatal and paediatric ICUs. Curr Opin Infect Dis 2009; 22: 224-228.
16. Saiman L. Strategies for prevention of nosocomial sepsis in the neonatal intensive care unit. Curr Opin Pediatr 2006; 18: 101-106.
17. O'Grady NP, Alexander M, Dellinger EP, Gerberding JL, Heard SO, Maki DG et al. Guidelines for the prevention of intravascular catheter-related infections. The Hospital Infection Control Practices Advisory Committee, Center for Disease Control and Prevention, U.S.. Pediatrics 2002; 110: e51.
18. Edwards WH. Preventing nosocomial bloodstream infection in very low birth weight infants. Semin Neonatol 2002; 7: 325-333.
19. Clark R, Powers R, White R, Bloom B, Sanchez P, Benjamin Jr DK. Prevention a Prevention and study of nosocomial sepsis in the NICU. J Perinatol 2004; 24:446-453.